Rua Bioscience is trading 10.71% down at NZD 0.03; no October 6 company announcement or credible report in the searched sources directly explains the decline.
- Its previously announced one-for-three rights offer remains open, with new shares priced at NZ$0.025; this earlier financing announcement does not establish the cause of the session’s move.
- Supplied broader-market figures show no meaningful index movement, leaving no clear market-wide explanation.